Acanthosis nigricans
☆ AI Dermatology — Free Service
U rezultatima Stiftung Warentest-a za 2022. iz Njemačke, zadovoljstvo potrošača ModelDerm-om bilo je samo nešto niže nego s plaćenim telemedicinskim konsultacijama.
U rezultatima Stiftung Warentest-a za 2022. iz Njemačke, zadovoljstvo potrošača ModelDerm-om bilo je samo nešto niže nego s plaćenim telemedicinskim konsultacijama.
Uobičajeno je kod gojaznih osoba.
relevance score : -100.0%
ReferencesAcanthosis nigricans je kožna manifestacija osnovnog poremećaja. Često se pojavljuje u kožnim naborima, poput vrata, pazuha i prepona, i izgleda kao baršunaste tamne mrlje s nejasnim rubovima. Ovo stanje je najčešće povezano s dijabetesom i rezistencijom na inzulin, ali u rijetkim slučajevima može ukazivati na rak u tijelu. Također se može pojaviti zbog hormonskih poremećaja ili uzimanja određenih lijekova, kao što su steroidi i kontracepcijske pilule.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans is a cutaneous manifestation of an underlying condition. It usually develops in skin folds, such as the back of the neck, axilla, and groin, where it presents as velvety hyper-pigmented patches with poorly defined borders. Acanthosis nigricans is most commonly associated with diabetes and insulin resistance, but rarely it can be a sign of internal malignancy. It can also occur with hormone disorders or with the use of certain medications like systemic glucocorticoids and oral contraceptives.
Acanthosis nigricans (AN) je uobičajeno stanje kože povezano s raznim zdravstvenim problemima, poput inzulinske rezistencije, dijabetesa, gojaznosti, određenih karcinoma, hormonskih poremećaja i reakcija na lijekove. Liječenje AN usmjereno je na rješavanje osnovnih zdravstvenih problema. Na početku liječnici provjeravaju postoje li znakovi sindroma inzulinske rezistencije, koji uključuje gojaznost, povišen holesterol, povišen krvni pritisak i dijabetes tipa 2. Doktori često propisuju topical retinoids kao prvi izbor tretmana, jer mogu pomoći kod zadebljanja kože, iako možda neće u potpunosti ukloniti hiperpigmentaciju. Ostale terapijske opcije, poput salicylic acid, podophyllin, urea i calcipotriol, također zahtijevaju čestu primjenu.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. Initial considerations for the AN workup include evaluating patients for insulin resistance syndrome characterized by obesity, dyslipidemia, hypertension, and diabetes mellitus type II. For cosmetic treatment, topical retinoids are considered the first-line therapy for insulin-resistant AN by modifying keratinization rate. However, topical tretinoin requires application for long durations and improves hyperkeratosis, but not hyperpigmentation. Topical salicylic acid, podophyllin, urea, and calcipotriol also require frequent application, while TCA peels may provide a faster and less time-intense burden.
○ Uzroci
Obično se javlja kod osoba mlađih od 40 godina, može biti genetski naslijeđena i povezana je s gojaznošću ili endokrinopatijama, kao što su hipotireoza, akromegalija, bolest policističnih jajnika, dijabetes rezistentan na inzulin ili Cushingova bolest.
○ Liječenje ― OTC lijekovi
40% urea krem